| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 12.171 | 16.270 | 17.531 | 14.019 | 13.804 | 17.009 | 26.658 | 34.800 | 44.886 |
| Total Income - EUR | - | 12.171 | 16.274 | 17.536 | 14.021 | 13.807 | 17.014 | 26.665 | 34.804 | 45.348 |
| Total Expenses - EUR | - | 4.131 | 6.376 | 7.511 | 7.422 | 5.321 | 5.374 | 7.495 | 15.627 | 25.575 |
| Gross Profit/Loss - EUR | - | 8.040 | 9.898 | 10.025 | 6.599 | 8.486 | 11.640 | 19.169 | 19.177 | 19.773 |
| Net Profit/Loss - EUR | - | 7.675 | 9.410 | 9.499 | 6.178 | 8.087 | 11.130 | 18.650 | 18.835 | 18.602 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 3 |
Check the financial reports for the company - Hahnemann Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 114 | 0 | 0 | 1.413 | 1.201 | 993 | 815 | 631 | 34.571 |
| Current Assets | - | 7.776 | 12.126 | 14.460 | 13.298 | 17.057 | 27.193 | 18.756 | 19.698 | 28.915 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 1.083 | 470 | 2.325 | 5.207 | 6.322 | 11.303 | 9.697 | 11.509 |
| Cash | - | 7.776 | 11.043 | 13.991 | 10.972 | 11.850 | 20.871 | 7.453 | 10.001 | 17.406 |
| Shareholders Funds | - | 7.720 | 9.454 | 14.052 | 14.711 | 17.144 | 27.893 | 18.707 | 18.886 | 32.478 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 170 | 2.672 | 408 | 0 | 1.114 | 293 | 863 | 1.443 | 31.009 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Hahnemann Med Srl